Sleep Number's first quarter 2024 results showed a net sales of $470 million and an adjusted EBITDA of $37 million, slightly above expectations. The company reduced operating expenses by $24 million year-over-year and increased free cash flow by $21 million compared to the prior year's first quarter. They reiterated their full-year 2024 adjusted EBITDA outlook of $125 million to $145 million.
Net sales reached $470 million, reflecting an 11% decline compared to the previous year, influenced by order backlog changes.
Adjusted EBITDA stood at $37 million, surpassing expectations due to increased operating model efficiencies.
Gross margin was 58.7%, showing a sequential improvement from the latter half of the prior year.
Free cash flow significantly increased year-over-year, and the company is prioritizing debt reduction and leverage.
The company reiterates its outlook for 2024 adjusted EBITDA of $125 million to $145 million. They continue to expect a mid-single digit net sales decline for the year on a low-single digit demand decline.
Visualization of income flow from segment revenue to net income